Potent Initiation Research Articles

Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.

Familial hypercholesterolaemia (FH) patients are subjected to a high lifetime exposure to low density lipoprotein cholesterol (LDL-C), despite use of lipid-lowering therapy (LLT). This study aimed to quantify the extent of subclinical atherosclerosis and to evaluate the association between lifetime cumulative LDL-C exposure and coronary atherosclerosis in young FH patients. Familial hypercholesterolaemia patients, divided into a subgroup of early treated (LLT initiated <25 years) and late treated (LLT initiated ≥25 years) patients, and an age- and sex-matched unaffected control group, underwent coronary CT angiography (CCTA) with artificial intelligence-guided analysis. Ninety genetically diagnosed FH patients and 45 unaffected volunteers (mean age 41 ± 3 years, 51 (38%) female) were included. Familial hypercholesterolaemia patients had higher cumulative LDL-C exposure (181 ± 54 vs. 105 ± 33 mmol/L ∗ years) and higher prevalence of coronary plaque compared with controls (46 [51%] vs. 10 [22%], OR 3.66 [95%CI 1.62-8.27]). Every 75 mmol/L ∗ years cumulative exposure to LDL-C was associated with a doubling in per cent atheroma volume (total plaque volume divided by total vessel volume). Early treated patients had a modestly lower cumulative LDL-C exposure compared with late treated FH patients (167 ± 41 vs. 194 ± 61 mmol/L ∗ years; P = 0.045), without significant difference in coronary atherosclerosis. Familial hypercholesterolaemia patients with above-median cumulative LDL-C exposure had significantly higher plaque prevalence (OR 3.62 [95%CI 1.62-8.27]; P = 0.001), compared with patients with below-median exposure. Lifetime exposure to LDL-C determines coronary plaque burden in FH, underlining the need of early as well as potent treatment initiation. Periodic CCTA may offer a unique opportunity to monitor coronary atherosclerosis and personalize treatment in FH.

Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome

Sarecycline is a new narrow-spectrum tetracycline-class antibiotic approved for the treatment of acne vulgaris. Tetracyclines share a common four-ring naphthacene core and inhibit protein synthesis by interacting with the 70S bacterial ribosome. Sarecycline is distinguished chemically from other tetracyclines because it has a 7-[[methoxy(methyl)amino]methyl] group attached at the C7 position of ring D. To investigate the functional role of this C7 moiety, we determined the X-ray crystal structure of sarecycline bound to the Thermus thermophilus 70S ribosome. Our 2.8-Å resolution structure revealed that sarecycline binds at the canonical tetracycline binding site located in the decoding center of the small ribosomal subunit. Importantly, unlike other tetracyclines, the unique C7 extension of sarecycline extends into the messenger RNA (mRNA) channel to form a direct interaction with the A-site codon to possibly interfere with mRNA movement through the channel and/or disrupt A-site codon-anticodon interaction. Based on our biochemical studies, sarecycline appears to be a more potent initiation inhibitor compared to other tetracyclines, possibly due to drug interactions with the mRNA, thereby blocking accommodation of the first aminoacyl transfer RNA (tRNA) into the A site. Overall, our structural and biochemical findings rationalize the role of the unique C7 moiety of sarecycline in antibiotic action.

The effect of Fe-rich intermetallics on crack initiation in cast aluminium: An in-situ tensile study

To evaluate the role of Fe-rich intermetallics on crack initiation, two fully modified Al-Si alloys, one containing plate-like β-Fe and the second containing primary α-Fe intermetallics, were investigated by in-situ tensile testing in the scanning electron microscope. In the first alloy, large plate-like β-Fe intermetallics oriented parallel to the test direction were the first to crack at an elongation of about 1.8%. More transversely oriented intermetallics caused crack initiation in the matrix which linked up with the final fracture. In the second alloy, the cracking of α-Fe intermetallics initiated at an elongation of about 0.9%. It is concluded that large α-Fe intermetallics crack first and that clusters of α-Fe are the most potent crack initiation sites.

Concordance between Results of Medium-term Liver Carcinogenesis Bioassays and Long-term Findings for Carcinogenic 2-Nitropropane and Non-carcinogenic1-Nitropropane in F344 Rats.

This study was conducted to determine the concordance of results for a pair of structural isomers, 2-nitropropane (2-NP) and 1-nitropropane (1-NP), using the rat medium-term liver carcinogenesis bioassay (Ito test) and previously published long-term carcinogenicity tests. Male F344 rats were given a single intraperitoneal injection of DEN (200 mg/kg b.w.) to initiate hepatocarcinogenesis. After 2 weeks, they received per os 0, 0.8, 4 or 20 mg/kg/day of 2-NP or 1-NP six times a week and were subjected to two-thirds partial hepatectomy at week 3. Non-initiated groups receiving 0 or 20 mg/kg/day were also included. The animals were sacrificed for quantitative analysis of GST-P-positive foci at week 8. With the highest dose of 2-NP, significantly increased numbers and areas of GST-P-positive foci were demonstrated as compared with the respective control but were not noted with 1-NP. In the non-DEN-initiated groups, many small GST-P-positive foci of less than 0.2 mm in diameter were also induced in the rats treated with 2-NP at 20 mg/kg/day but were lacking with 1-NP. These results strongly support that 2-NP is a complete hepatocarcinogen with a potent initiation activity, whereas 1-NP is not.

GroEL-induced topological dislocation of a substrate protein β-sheet core: a solution EPR spin–spin distance study

The Hsp60-type chaperonin GroEL assists in the folding of the enzyme human carbonic anhydrase II (HCA II) and protects it from aggregation. This study was aimed to monitor conformational rearrangement of the substrate protein during the initial GroEL capture (in the absence of ATP) of the thermally unfolded HCA II molten-globule. Single- and double-cysteine mutants were specifically spin-labeled at a topological breakpoint in the β-sheet rich core of HCA II, where the dominating antiparallel β-sheet is broken and β-strands 6 and 7 are parallel. Electron paramagnetic resonance (EPR) was used to monitor the GroEL-induced structural changes in this region of HCA II during thermal denaturation. Both qualitative analysis of the EPR spectra and refined inter-residue distance calculations based on magnetic dipolar interaction show that the spin-labeled positions F147C and K213C are in proximity in the native state of HCA II at 20°C (as close as ∼8Å), and that this local structure is virtually intact in the thermally induced molten-globule state that binds to GroEL. In the absence of GroEL, the molten globule of HCA II irreversibly aggregates. In contrast, a substantial increase in spin-spin distance (up to >20Å) was observed within minutes, upon interaction with GroEL (at 50 and 60°C), which demonstrates a GroEL-induced conformational change in HCA II. The GroEL binding-induced disentanglement of the substrate protein core at the topological break-point is likely a key event for rearrangement of this potent aggregation initiation site, and hence, this conformational change averts HCA II misfolding.

Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapy

Thrombolysis is the only effective pharmaceutical therapy in acute ischemic stroke in humans but has a high risk of intracerebral hemorrhage. We aimed to establish an animal model to study changes of coagulation and fibrinolytic parameters during thromboembolic ischemic stroke and thrombolysis with recombinant tissue plasminogen activator (rt-PA). We used a thromboembolic stroke model in the rat. Animals were treated with rt-PA thrombolysis (n=10) and compared with untreated (n=10), sham operated (n=10) and control animals (n=20). Coagulation parameters (APTT, PT, TT, fibrinogen, AT III, TAT) and fibrinolytic parameters (t-PA antigen concentration, t-PA activity, PAI-1 concentration, PAI activity, plasminogen, antiplasmin) were measured at two time points (2.5 and 5h after stroke induction) with a battery of commercially available test kits. We observed an (1) initiation of coagulation and inhibition of fibrinolysis by the operation procedure itself, (2) simultaneous activation of fibrinolysis and its inhibitors after stroke induction and (3) potent initiation of fibrinolysis and consumption of fibrinolysis inhibitors after rt-PA therapy of stroke. We established a model system to monitor coagulation and fibrinolysis during thrombolytic therapy of stroke in the rat. This model may be used to study the influence of these parameters on hemorrhagic stroke transformation and outcome in experimental stroke in future.

Carcinogens and endemic squamous cancer of the oesophagus in Transkei, South Africa. Environmental initiation is the dominant factor; tobacco or other carcinogens of low potency or concentration are sufficient for carcinogenesis in the predisposed mucosa

Oesophageal cancer is common in Africa, and is a major cause of death in Transkei, South Africa. The cause of this endemic disease has been debated for many decades. A continuing focus of research has been identification of a single potent carcinogen. I argue that endemic incidence of oesophageal cancer is associated with potent initiation, not with potent carcinogenesis. Tobacco is a known oesophageal carcinogen, and there is very strong evidence that it is causally involved in a significant proportion of victims. Other potential carcinogens present in the environment include fungal mycotoxins, human papillomavirus, Solanum nigrum and nitrosamines. These are all of lower carcinogenic potential for the oesophagus, and do not have strong evidence associating them with the disease. In the presence of potent environmental initiation, any oesophageal carcinogen even if of low potency or of low concentration may cause the disease. Any or all of the substances named above may be involved, any one of them the cause of the final carcinogenic change in the individual. Tobacco exemplifies this point. It is of relatively low concentration/usage in Transkei, yet has an undeniable association with oesophageal cancer. Carcinogenesis for the oesophagus in Transkei is solely or predominantly due to agents which are already known, including tobacco, acting on a predisposed mucosa. The search for further carcinogens is of low importance, and the search for a single potent carcinogen is misguided. What is of importance is the development of methods to reduce the risks associated with predisposing factors and with known carcinogens.

Microstructural Analysis of Fatigue Initiation in Al-Si Casting Alloys

Fatigue initiation behaviour in three multi-component Al-Si casting alloys with varying Si content is compared using a range of microscopy and analytical techniques. A higher proportion of stiffer secondary phases leads to load transfer effects reducing particle cracking and particle/matrix debonding. Si appears stronger than the Al9FeNi phase, which cracks and debonds to form initiation sites preferentially over Si. Reducing Si content results in clusters of intermetallics forming, and increased porosity. The effect of porosity, combined with mesoscopic load transfer effects to the high volume fraction intermetallic regions make these potent crack initiation sites in low silicon alloys.

Nonnative Capping Structure Initiates Helix Folding in an Annexin I Fragment. A 1H NMR Conformational Study

A 21-residue peptide, P1AQFD5ADELR10AAMKG15LGTDE20D, corresponding to the (helix A)-loop motif of the second repeat of human annexin I, was synthesized and studied by 2D proton NMR. The conformational properties of the peptide were characterized at different temperatures in pure aqueous solution and in a TFE/H2O (1:4 v/v) mixture. In pure aqueous solution, the peptide adopts a preferred conformation, comprising both elements of native and nonnative structures. A high alpha helix content is present in the DADELRA segment, which corresponds to an initiation site in the middle of the native alpha helix sequence. At the N-terminus flanking region, a particular nonnative folding is revealed by the J(NH-CH alpha) coupling constants and a set of unusual NOE connectivities which correspond to a helix interrupt at the first D residue. Addition of relatively small amount of TFE restores the native helix fold at the C-terminus but not at the N-terminus. On the contrary, the nonnative N-terminus structure is clearly stabilized by TFE. Our data indicate that this structure comprises (i) an Asp5-x-x-Glu8 N-terminal capping box, as recently named by Harper and Rose [Harper, E. T., & Rose, G. D. (1993) Biochemistry 32, 7605-7609], (ii) a (i,i + 3) Asp7-x-x-Arg10 salt bridge, and (iii) a hydrophobic cluster centered on Phe4 which mainly interacts with Leu9 but also with Ala2, Ala6, and Ala12 in a dynamic way. This structure is rather stable since it is still observed at 293 K in aqueous solution and 313 K in the presence of TFE. It constitutes a very potent initiation site of the alpha helix structure. This is, however, a nonnative structure involving highly conserved residues in the whole annexin family and thus may play an important role in the folding pathway as a transient "compacting helper".

Microstructural trapping effects on hydrogen induced cracking of a microalloyed steel

The susceptibility of a Ti microalloyed HSLA steel to internal hydrogen induced cracking has been correlated with the hydrogen trapping character of the microstructure. Both of these properties are influenced by aging reactions which determine the type and extent of carbide precipitation as well as metalloid segregation to grain boundarie. In turn, crack path susceptibility and total trapping character determine in large part the threshold and steady-state cracking propensities. Thus, metalloid segregation concurrent with potent irreversible trap (TiC) precipitation results in low inherent toughness, but no appreciables drop in threshold stress intensity. Conversely, cementite precipitates formed at lower aging temperatures provide potent crack initiation sites in the absence of deep trapping, resulting in a lower threshold for cracking.

Microstructural effects on the cleavage fracture stress of fully pearlitic eutectoid steel

The microstructural parameter(s) controlling the critical cleavage fracture stress, σF, of fully pearlitic eutectoid steel have been investigated. Independent variation of the pearlite interlamellar spacing,Sp, and the prior austenite grain size were accomplished through heat treatment. Critical cleavage fracture stresses were measured on bluntly-notched bend specimens tested over the temperature range -125 °C to 23 °C. The cleavage fracture stress increased with decreasingSp, and was independent of prior austenite grain size. Fine pearlitic microstructures exhibited temperature, strain-rate, and notched-bar geometry independent values for σF, consistent with propagation-controlled cleavage fracture. Coarse pearlitic specimens exhibited temperature-dependent values for σF over a similar temperature range. Inclusion-initiated fractures were generally located at or beyond the location of the peak normal stress in the bend bar, while cracking associated with pearlite colonies was observed to be closer to the notch than the predicted peak stress location. The calculated values for σF were independent of both the type and location of initiation site(e. g., inclusion, pearlite colony). Thus, although inclusions may provide potent fracture initiation sites, their presence or absence does not necessarily change σF in fully pearlitic microstructures.

Modifying factors in urinary bladder carcinogenesis.

N-Butyl-N-(4-hydroxybutyl)nitrosamine (BBN) is a potent carcinogen in the urinary bladder of animals. The BBN model of bladder cancer is an excellent model of human urinary bladder cancer and has already led to a greater knowledge of its pathogenesis. In our studies, histogenesis and morphological characteristics of BBN urinary bladder cancer were analyzed in different animal species such as rats, mice, hamsters and guinea pigs and also in different rat strains. Papillary or nodular hyperplasia (PN hyperplasia) is found to be a preneoplastic lesion of the rat urinary bladder. Therefore, the promoting and inhibitory effects of various chemicals in two-stage urinary bladder carcinogenesis were judged by measuring PN hyperplasia in rats. Dose-dependent and organ-specific effects of the urinary bladder promoter, saccharin, in the induction of PN hyperplasia were shown in rats after initiation by BBN. The promoting effect of saccharin was seen more clearly in the urinary bladder of rats after potent initiation. A strain difference in susceptibility of the urinary bladder to the promoter was also shown. These results suggest that the above various factors may also have modifying activities on urinary bladder carcinogenesis in man.

Modifying Factors in Urinary Bladder Carcinogenesis

N-Butyl-N-(4-hydroxybutyl)nitrosamine (BBN) is a potent carcinogen in the urinary bladder of animals. The BBN model of bladder cancer is an excellent model of human urinary bladder cancer and has already led to a greater knowledge of its pathogenesis. In our studies, histogenesis and morphological characteristics of BBN urinary bladder cancer were analyzed in different animal species such as rats, mice, hamsters and guinea pigs and also in different rat strains. Papillary or nodular hyperplasia (PN hyperplasia) is found to be a preneoplastic lesion of the rat urinary bladder. Therefore, the promoting and inhibitory effects of various chemicals in two-stage urinary bladder carcinogenesis were judged by measuring PN hyperplasia in rats. Dose-dependent and organ-specific effects of the urinary bladder promoter, saccharin, in the induction of PN hyperplasia were shown in rats after initiation by BBN. The promoting effect of saccharin was seen more clearly in the urinary bladder of rats after potent initiation. A strain difference in susceptibility of the urinary bladder to the promoter was also shown. These results suggest that the above various factors may also have modifying activities on urinary bladder carcinogenesis in man.

Non-enzymic binding of formylmethionyl-transfer RNA f to Artemia satina ribosomes

40 S ribosomal subunits of Artemia salina embryos can bind formylmethionyl-transfer RNA f non-enzymically, i.e., in the absence of initiation factors. This, like the enzymic reaction, is largely AUG-dependent. Much more fMet-tRNA f is bound by 80 S ribosomes but, in this case, a large fraction (about two-thirds) of the binding is AUG-independent. Whereas the AUG-dependent binding is very sensitive to edeine, a potent initiation inhibitor, the AUG-independent binding is resistant to this antibiotic. Virtually all of the bound fMet-tRNA f is in all cases capable of reacting with puromycin to form fMet-puromycin; hence the bound aminoaoyl-tRNA is in the peptidyl (donor) site of the 80 S ribosome. Non-acylated tRNAs also bind to this site with high affinity in a codon-independent reaction and block the 80 S binding of fMet-tRNA f. The properties of the peptidyl site are consistent with a non-decoding site which harbors the initiator aminoacyl-tRNA, when the 80 S initiation complex is formed, and to which every molecule of tRNA remains temporarily attached following peptide bond synthesis.